This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stock Futures Pare Losses After Retail Sales Number

Stocks in this article: ^DJI ^GSPC ^IXIC ELN THRX YUM CCL

NEW YORK ( TheStreet) -- Stock futures were paring losses Monday after a rise in an April retail sales report, pointing to positive trends in U.S. growth.

Futures for the S&P 500 were off 2.25 points, or 3.15 points below fair value, to 1,627.25.

The Census Bureau reported Monday that retail sales rose 0.1% in April after falling by a revised 0.5% in March. Excluding autos, retail sales fell 0.1% after dipping 0.4%. Economists, on average, were expecting retail sales to fall 0.3% in April, and excluding autos, to dip 0.1%.

Business inventories are forecast to have increased 0.3% in March after rising 0.1% in February. The Census Bureau releases this data at 10 a.m. EDT.

Data from the world's second-largest economy was also weighing on sentiment, with China's April industrial output report rising only mildly and disappointing expectations. The modest increase in April retail sales also added to worries about a feeble economic recovery in China. The country also reported that its fixed-asset investment unexpectedly decelerated in April.

"This set of data still suggests a painfully slow mend of China's growth momentum," Yao Wei, a Hong Kong-based economist with Societe Generale SA, wrote in a report.

Carnival (CCL) shares were shedding more than 1% to $34.72 as investors continue to digest the troubles that have hit the cruise line operator, with the latest event being two Australian passengers who went missing in the ocean after falling out the cruise ship. The search for the two was called off Friday. The company has provided assurances that its railings are more than sufficiently high to prevent accidental falls.

Elan (ELN) and Theravance (THRX) reached a $1 billion agreement in which Elan will buy 21% of royalties that Theravance receives from GlaxoSmithKline (GSK) for four respiratory drugs. Elan shares were slipping 0.34% to $11.74, while Theravance was surging more than 12% to $39.25.

The deal includes Breo Ellipta, a new treatment for chronic obstructive pulmonary disease that received approval from the Food and Drug Administration last week.

Yum! Brands (YUM), the owner of KFC, Pizza Hut and Taco Bell said Friday that sales in China fell 29% in April, damaged by bird flu scares.

Futures for the Dow Jones Industrial Average were falling 17 points, or 25.49 points below fair value, to 15,051. Futures for the Nasdaq were down 4 points, or 5.92 points below fair value, to 2,971.5.

The Hong Kong Hang Seng Index finished down 1.42% Monday. The Nikkei 225 in Japan closed up 1.2%. The FTSE 100 in the UK was falling 0.27% and the DAX in Germany was down 0.64%.

June gold futures were down $9.40 to $1,427.20 an ounce. June oil futures were sliding $1.15 to $94.89 a barrel.

The benchmark 10-year Treasury was rising 2/32, diluting the yield to 1.897%. The dollar was up 0.04% to $83.18 according to the U.S. dollar index.

Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs